Identification of alternative splicing-derived cancer neoantigens for mRNA vaccine development.

Cheng, Rui; Xu, Zhaochun; Luo, Meng; Wang, Pingping; Cao, Huimin; Jin, Xiyun; Zhou, Wenyang; Xiao, Lixing; Jiang, Qinghua

Cheng, Rui; Xu, Zhaochun; Luo, Meng; Wang, Pingping; Cao, Huimin; Jin, Xiyun; Zhou, Wenyang; Xiao, Lixing; Jiang, Qinghua.

Afiliação

Cheng R; Harbin Institute of Technology, China.
Xu Z; Harbin Institute of Technology, China.
Luo M; Harbin Institute of Technology, China.
Wang P; Harbin Institute of Technology, China.
Cao H; Harbin Institute of Technology, China.
Zhou W; Harbin Institute of Technology, China.
Xiao L; Harbin Institute of Technology, China.
Jiang Q; Harbin Institute of Technology, China.

Brief Bioinform ; 23(2)2022 03 10.

Article em En | MEDLINE | ID: mdl-35279714

Assuntos

Processamento Alternativo; Neoplasias; Antígenos de Neoplasias/genética; Humanos; Imunoterapia; Neoplasias/genética; Neoplasias/terapia; RNA Mensageiro/genética; Vacinas Sintéticas; Vacinas de mRNA

Palavras-chave

alternative splicing-derived cancer neoantigens; cancer immunotherapy; computational identification of cancer neoantigens; mRNA vaccine

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Processamento Alternativo / Neoplasias Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Brief Bioinform Assunto da revista: BIOLOGIA / INFORMATICA MEDICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google